600513.SH
联环药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 15.64
−6.01%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
67.5x
Market Cap
CNY 4.46B
MomentumView details →
1D Return
−6.01%
YTD Return
−14.96%
RSI (14)
41.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
67.5x
Market Cap
CNY 4.46B
RSI (14)
41.3
MomentumView details →
1D Return
−6.01%
YTD Return
−14.96%
Similar companies
Latest newsMore news →
Lianhuan Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 10.5218 million yuan, turning from a loss in the same period last year.8d agoLianhuan Pharmaceutical's board approved its subsidiary Lianhuan (Nanjing) Medical Technology to borrow 10 million yuan from related party Jiangsu Lianhuan Health Industry Management Development at an annual interest rate of 2.5% for up to 3 months.25d ago